This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Bioarctic Neuroscience Ab, University of South Florida. Active years: 2004-2010.
Company Filing History:
Years Active: 2004-2010
Title: The Innovative Contributions of Lars Nilsson
Introduction
Lars Nilsson is a prominent inventor based in Uppsala, Sweden. He has made significant contributions to the field of neuroscience, particularly in the study of Alzheimer's disease. With a total of 2 patents, his work focuses on developing transgenic models that aid in understanding and treating neurological disorders.
Latest Patents
Lars Nilsson's latest patents include a transgenic mouse expressing the Arctic mutation E693G. This transgenic non-human animal expresses at least one transgene that encodes a heterologous Amyloid Precursor Protein (APP), which includes the Arctic mutation and potentially other Alzheimer's disease pathogenic mutations. This innovation results in increased amounts of intracellular soluble A aggregates, including A peptides. The patent also discloses methods for producing the transgenic animal and screening for therapeutic or diagnostic agents useful in the treatment or diagnosis of Alzheimer's disease. Another notable patent involves a transgenic animal, preferably a mouse, that expresses human antichymotrypsin (ACT) in brain tissues. This invention provides animal tissue-derived cell lines and progeny animals, which can be used for testing compounds aimed at treating various neurological diseases.
Career Highlights
Lars Nilsson has worked with esteemed institutions such as the University of South Florida and Bioarctic Neuroscience AB. His research has significantly advanced the understanding of Alzheimer's disease and related neurological disorders.
Collaborations
Throughout his career, Lars has collaborated with notable figures in the field, including Huntington Potter and Gary W. Arendash. These collaborations have further enriched his research and contributions to neuroscience.
Conclusion
Lars Nilsson's innovative work in developing transgenic models for Alzheimer's disease has made a lasting impact on the field of neuroscience. His patents and collaborations continue to pave the way for advancements in the treatment and understanding of neurological disorders.